Welcome to our dedicated page for Nextgen Healthcare news (Ticker: NXGN), a resource for investors and traders seeking the latest updates and insights on Nextgen Healthcare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nextgen Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nextgen Healthcare's position in the market.
NextGen Healthcare (NASDAQ: NXGN) announced its partnership with Compass Health Network, which has adopted the NextGen Behavioral Health Suite. This comprehensive software solution aims to enhance whole-person care for over 100,000 patients across 84 locations in Missouri. The integration of various health services, including primary care and oral health, seeks to improve healthcare outcomes through a unified platform. According to a 2021 survey, 51% of behavioral health providers have implemented whole-person care, highlighting a growing focus on integrated healthcare solutions.
NextGen Healthcare (Nasdaq: NXGN) announced it has achieved top rankings in the 2023 Ambulatory EHR PM User Survey from Black Book Research for the sixth consecutive year. The company was recognized as the No. 1 Electronic Health Record (EHR) and Practice Management (PM) solution across various physician group sizes. It earned the most top rankings of any vendor in 40 specialties, including first place in the FQHC/CHC category. Client satisfaction data from over 800,000 ballots contributed to this ranking, underscoring NextGen's commitment to health equity and client productivity.
Summary not available.
NextGen Healthcare, Inc. (Nasdaq: NXGN) reports fiscal Q3 2023 revenue of $161.9 million, up 8% year-over-year, with recurring revenue increasing 11% to $148.7 million. Non-recurring revenue fell 14% to $13.2 million. Bookings reached $44.8 million, including six deals over $1 million. Fully diluted EPS rose to $0.12, while non-GAAP EPS increased to $0.26. The company has raised its fiscal 2023 revenue guidance to $642-$650 million, and maintains adjusted EBITDA guidance of $110-$115 million. Their positive outlook reflects successful capital management and strategic acquisitions, such as TSI Healthcare.
NextGen Healthcare, Inc. (NASDAQ: NXGN) will release its fiscal 2023 third quarter earnings on January 24, 2023, after market close. A conference call is scheduled for 5 p.m. EST the same day, where shareholders can participate by calling 800-343-4849 or 785-424-1699 (international). A recording will be available for 90 days on their investor relations site. NextGen focuses on innovative healthcare technology solutions aimed at improving patient outcomes and enhancing healthcare practices.
NextGen Healthcare (NASDAQ: NXGN) announced the integration of the NextGen Patient Experience Platform and NextGen Pay into Eye Health America's ambulatory platform. This move aims to enhance patient experiences by allowing real-time appointment scheduling and online payments, while providing quick access to medical records. The integration is part of a strategy to reduce clinician burnout and streamline workflows across Eye Health America’s clinics in the Southeastern U.S., aligning with their patient-centric focus.
NextGen Healthcare (Nasdaq: NXGN) announced that its Mirth® Connect clinical data exchange solution has achieved the 2015 Edition Cures Update certification from the ONC Health IT. This certification confirms compliance with stringent data security standards, supporting interoperability among healthcare providers. Mirth Connect, praised for its flexibility and functionality, is utilized globally in various healthcare settings, enhancing data integrity and security. This certification illustrates NextGen's commitment to leading in secure data exchange, contributing to improved patient outcomes.
NextGen Healthcare (NASDAQ: NXGN) announced participation in the 41st Annual J.P. Morgan Healthcare Conference on January 11 at 3 p.m. Pacific Time. CEO David Sides and CFO Jamie Arnold will present the company's innovative cloud-based healthcare technology solutions aimed at enhancing patient care and practice efficiency. A recording of the presentation will be accessible at investor.nextgen.com for 90 days. The company continues to seek improvements in healthcare outcomes through integrated, interoperable solutions.
NextGen Healthcare (NASDAQ: NXGN) announced that its clients in the Medicare Shared Savings Program saved a total of
Brightside Health announced the appointment of Jeff Margolis as an independent board member and David Shulkin, MD, as an advisor, effective October 1, 2022. Both experts will guide the company in expanding telehealth solutions for mental health care, particularly for severe conditions. Margolis brings extensive experience in healthcare technology, while Shulkin's background includes leadership roles in major health systems and the Veterans Affairs Department. Their expertise is expected to enhance Brightside's strategic decisions and market execution in behavioral health.
